Concepedia

Aleksandr V. Yurkovetskiy

AV

2

Publications

116

Citations

2

H-Index

2021

Active since

Affiliations

Mersana Therapeutics (United States)(Current)

Aleksandr V. Yurkovetskiy is an author at Mersana Therapeutics (United States).

ORCID

Publications per year

2021–2021

2

Publications

2

Dolaflexin: A Novel Antibody–Drug Conjugate Platform Featuring High Drug Loading and a Controlled Bystander Effect

Aleksandr V. Yurkovetskiy, Natalya D. Bodyak, Mao Yin et al. · Molecular Cancer Therapeutics · 2021 · 70 citations · Full text

The Dolaflexin-based Antibody–Drug Conjugate XMT-1536 Targets the Solid Tumor Lineage Antigen SLC34A2/NaPi2b

Natalya D. Bodyak, Rebecca Mosher, Aleksandr V. Yurkovetskiy et al. · Molecular Cancer Therapeutics · 2021 · 46 citations · Full text

Rows per page

1–2 of 2